Objective
To evaluate the impact of the Neonatal Resuscitation Program (NRP) recommended low oxygen strategy on neonatal morbidities, mortality and neurodevelopmental outcomes in preterm neonates.
Study design
In March 2011, Parkland Hospital changed from a high oxygen strategy (HOX) of resuscitation with initial 100% O2 and targeting 85–94% SpO2 for delivery room (DR) resuscitation to a low oxygen strategy (LOX) with initial 21% O2 and titrating O2 to meet NRP recommended transitional target saturations. Neonates ≤28 weeks gestational age (GA) born between August 2009 and April 2012 were identified. In this retrospective, observational study, neonates exposed to LOX versus HOX were compared for short-term morbidity, mortality and long-term neurodevelopmental outcomes. Regression analysis was performed to control for confounding variables.
Results
Of 199 neonates, 110 were resuscitated with HOX and 89 with LOX. Compared with HOX, LOX neonates had lower O2 exposure in the DR (5.2 ± 1.5 vs 7.8 ± 2.8 (ΣFiO2 × Time min), P < .01), spent fewer days on O2 (30 (5, 54) vs 46 (11, 82), p=0.01) and had lower odds of developing bronchopulmonary dysplasia (BPD) (adjusted odds ratio 0.4(0.2, 0.9)). There was no difference in mortality (17(20%) vs 20(18%)), but LOX neonates had higher motor composite scores on Bayley III assessment (91 (85, 97) vs 88 (76, 94), p<0.01).
Conclusion
The NRP recommended LOX strategy was associated with improved respiratory morbidities and neurodevelopmental outcomes with no increase in mortality. Prospective trials to confirm the optimal oxygen strategy for the resuscitation of preterm neonates are needed.